NanoMedical Systems raised $4.1 million in a new round of financing, according to a regulatory filing. The Delaware-based company offered equity and warrants to the 46 investors that contributed to the round. The company did not disclose how it plans to use its newly-acquired funds. No money from the round is slated to compensate sales […]
Pharmaceutical
Researchers use shock waves, nanoparticles to deliver chemo drugs
Researchers from the University of Turin demonstrated that combining shock waves with nanoparticles can help deliver chemotherapy to tumors in animal models. The team’s work was published in the journal, Endocrine-Related Cancer. Researchers designed the treatment to use extracorporeal shock waves and nanobubbles to more effectively target the cancer drugs to the tumor site. Get the […]
Propeller Health: From hardware startup to analytics leader
Seven years after the digital respiratory startup Propeller Health launched, co-founder and chief technology officer Greg Tracy told a crowd at this year’s Medical Sensors Design Conference that what started as an attempt to build sensors for respiratory devices has slowly evolved into a “hardware-enabled software company.” “We thought that we were going to go build […]
Teva beats estimates for Q1 earnings
Shares in Teva Pharmaceutical (NYSE:TEVA) fell slightly in pre-market activity today after the pharmaceutical company beat earnings expectations on Wall Street with its 1st quarter results. The Israel-based company posted profits of $641 million on sales of $5.63 billion for the 3 months ended March 31, for bottom-line growth of 1.3% on sales growth of 17% compared […]
GSK dodges bullet after another generic Advair competitor is denied
GlaxoSmithKline (NYSE:GSK) will not likely face generic competition to its lung drug Advair in the US this year. Yesterday, the FDA denied the application for a 2nd generic competitor. Hikma Pharmaceuticals (LON:HIK) disclosed today that the FDA decided not to approve its version of the inhaled asthma treatment, due to “major” problems with the application. This comes […]
OncoSec inks deal with Merck to study drug-device therapy for metastatic melanoma
OncoSec Medical (NSDQ:ONCS) said today that it inked a clinical trial collaboration and supply agreement with Merck (NYSE:MRK) to evaluate the combination of its ImmunoPulse IL-12 electroporation device with Merck’s Keytruda therapy in a Phase II clinical trial. The trial aims to evaluate the drug-device combination in patients with metastatic melanoma – specifically patients who experienced disease […]
Halo Pharma launches development & manufacturing facility for pediatric drugs
Halo Pharma launched its Pediatic Center of Excellence today to support the development and manufacturing of drugs tailored for pediatric indications. The company said it will use the manufacturing facility to continue working with pharmaceutical companies to develop pediatric dosage forms of already-approved adult drugs. When the FDA requests that a company conduct clinical trials for […]
Nobilis, Submersible Systems to develop hand-held inhalation device for neurological drugs
Nobilis Therapeutics said today that it partnered with device manufacturer Submersible Systems to develop a portable, hand-held inhalation device that administers a xenon gas-based therapeutic, NBTX-001. The companies said they are working on customizing and testing the drug-device combination. The group plans to pursue regulatory approval with the FDA, supported by upcoming clinical trials in […]
Patients with Parkinson’s disease help to shape clinical trial design
Margaret Sheehan isn’t a scientist, but she is 1 of many patient scientists joining an effort to incorporate Parkinson’s patients’ preference into the design of clinical trials for new treatments. Sheehan, a Virginia-based lawyer, has had Parkinson’s disease since 2004. She told Drug Delivery Business News that when the folks at the Medical Device Innovation Consortium presented last spring […]
Mylan beats Q1 earnings by a penny, misses on revenue
Shares in Mylan (NSDQ:MYL) rose 2% in pre-market activity today after the EpiPen maker beat earnings expectations on Wall Street with its 1st quarter results. The Canonsburg, Penn.-based company posted profits of $66.4 million, or 12¢ per share, on sales of $2.72 billion for the 3 months ended March 31, for bottom-line growth of 377.7% on sales growth […]
Researchers combine modified insulin and red blood cells to regulate blood sugar in diabetic mice
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have designed a glucose-responsive “smart” insulin delivery system using modified insulin and red blood cells. In an animal study of mice with Type I diabetes, the system effectively reduced blood sugar levels for 48 hours. The team’s work was published […]